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Matrix metalloproteinase-9Our previous research found that tetraspanin CD9 is downregulated in migrating epidermis during
wound healing, and CD9 downregulation contributes to keratinocyte migration via matrix
metalloproteinase-9 (MMP-9) activation. However, little is known about the mechanisms involved
in CD9-regulated keratinocyte migration and MMP-9 activation. In this study, we revealed that
the expressions of integrin subunits b5 and b6 were regulated by CD9. Furthermore, CD9 silencing
triggered the switch from avb5 to avb6 integrin in HaCaT keratinocytes and CD9 overexpression
reversed the switch. Importantly, integrin avb6 functional blocking antibody 10D5 signiﬁcantly
inhibited CD9 silencing-induced keratinocyte migration and MMP-9 activation, suggesting that
the switch from avb5 to avb6 integrin plays a key role in CD9-regulated cell migration and
MMP-9 activation in keratinocytes.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Wound healing is a dynamic and well-ordered biological pro-
cess requiring the collaborative efforts of many different tissues
and cell lineages [1,2]. Keratinocyte migration is an early event
in the re-epithelialization process, an essential step for wound
healing [3]. The behavior of keratinocyte migration, matrix synthe-
sis, and signaling pathways present at a wound site are roughly
understood. Our previous results revealed that CD9, a member of
the tetraspanin superfamily, is critical for cutaneous wound heal-
ing. CD9 is downregulated in migrating epidermis and re-elevated
to the basal level when re-epithelialization is complete [4]. CD9 is
an integral transmembrane protein comprised of four transmem-
brane domains, two extracellular loops, and short intracellular
ends [5,6] and has been implicated in various cellular and physio-
logical processes like cell motility, migration, and adhesion [7].
Moreover, we also found that CD9 downregulation enhances kerat-
inocyte migration by upregulating matrix metalloproteinase-9
(MMP-9) [8]. MMP-9, a gelatinase subclass, was revealed tocontribute to keratinocyte migration during wound repair [9–11].
However, little is known about how CD9 regulates keratinocyte
migration and MMP-9.
Integrins are heterodimeric transmembrane receptors that
comprise the a- and b-subunit for extracellular matrix (ECM),
which play important roles in embryonic development, wound
healing, inﬂammation, and tumorigenesis [12]. The activity of
integrins must be regulated to execute the function, either by out-
side-in signals from ECM or inside-out signals from multiple intra-
cellular pathways [13,14]. Integrins known to be expressed in the
epithelium include integrins a3b1, a6b4, avb5, and avb6 [15].
Interestingly, avb6 is not expressed constitutively in healthy epi-
thelia but is upregulated during tissue remodeling, including
wound healing and carcinogenesis [16,17]. Aslo, freshly isolated
epidermal keratinocytes do not stain for avb6 integrin but begin
to express after subculturing [18]. Successful epithelial wound
healing is associated with speciﬁc integrin changes in the cell-
matrix adhesion process and extracellular matrix degradation
[19]. av forms a heterodimer exclusively with b5 in normal epider-
mis [20]. Both avb5 and avb6 are expressed in hyperproliferative
stratiﬁed squamous epithelia [18]. Reepithelialization is associated
with a switch from avb5 to avb6 during cutaneous wound healing
[21]. The down-regulation of avb5 in association with avb6
expression probably reﬂects a hierarchy in the preference of av
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well-ordered change during wound repair [4] and is implicated
in many integrin regulations [23,24]. Moreover, avb6 integrin is
revealed to promote corneal wound repair [25], upregulate MMP-
9, and promote cell migration in normal oral keratinocytes [26].
Increasing research found that avb6 integrin is involved in promot-
ing MMP-9 expression and cell migration [27–29]. Hence, we
hypothesized that CD9 regulates the switch from avb5 to avb6
integrin, which participates in keratinocyte migration and MMP-
9 expression.
In the present study, we found that CD9 downregulation trig-
gered the switch from avb5 to avb6 integrin in HaCaT keratino-
cytes and CD9 overexpression reversed the switch. Furthermore,
CD9 silencing-induced keratinocyte migration and MMP-9 activa-
tion and expression were signiﬁcantly inhibited by avb6 integrin
functional blocking, while avb5 integrin had no effect in the pro-
cesses. Thus, we report here, for the ﬁrst time, that the switch from
avb5 to avb6 integrin plays a key role in CD9-regulated cell migra-
tion and MMP-9 activation in keratinocytes.
2. Materials and methods
2.1. Cell culture
HaCaT keratinocytes were obtained from Cell Bank of the Chi-
nese Academy of Sciences in Beijing, China. Cells were cultured
in RPMI 1640 medium (Hyclone, USA) supplemented with 100 U/
mL penicillin, 100 mg/mL streptomycin, and 10% fetal bovine
serum (Hyclone, USA). The cells were incubated at 37 C, 5% CO2,
and 95% humidity.
2.2. Recombinant adenovirus vectors for CD9 expression silencing or
overexpressing
The recombinant adenovirus vectors for silencing CD9 expres-
sion (siCD9) or overexpressing CD9 (Ad-CD9) and the negative vec-
tor containing non-speciﬁc shRNA (siCtr) and the negative control
adenovirus vector (Vector) were purchased from Shanghai Gene-
Chem, Co. Ltd (Shanghai, China). All vectors contained the gene
for GFP, which served as a marker. HaCaT cells were infected with
these vectors at a multiplicity of infection of 10 for 48 h for these
experiments.
2.3. Western blot
Cells were washed twice with ice-cold phosphate-buffered sal-
ine (PBS) and collected in 1 loading buffer on ice, and homoge-
nized. Protein concentration was determined by RCDC protein
assay kit (Sigma, USA). Cell lysates were resolved by SDS–PAGE
and transferred to polyvinylidene diﬂuoride (PVDF) membranes
according to standard procedures. The membranes were blocked
with 5% skim milk and probed with primary antibodies for b5,
b6, b1, av, and a3 (1:1000; Santa Cruz Biotechnology, USA) and
MMP-9 (1:1000; Abcam, USA) anti-GAPDH at 1:5000 dilution.
Horseradish peroxidase-conjugated IgG was used as a secondary
antibody and GAPDH was used as loading control. The results were
analyzed with ChemiDoc imaging system (Bio-Rad, USA).
2.4. Immunoprecipitation
To analyze the integrin subunit avb5 and avb6 complex forma-
tion at the plasma membrane, equal amounts of membrane protein
(500 lg) extracted with the Plasma Membrane Protein Extraction
Kit (Biovision, USA) were incubated with 2 lg of anti-av antibody
for 1 h at room temperature and then the complexes wereprecipitated with protein A/G-Sepharose (Santa Cruz) overnight
at 4 C. The lysate-antibody-agarose bead mixture was washed
four times with PBS and then probed with anti-b5, anti-b6, and
anti-av (1:1000 dilution) (Santa Cruz Biotechnology, USA) using
Western blot.
2.5. Immunoﬂuorescence microscopy
Cells cultured on ﬁbronectin-coated glass coverslips were ﬁxed
in 4% paraformaldehyde for 20 min. The ﬁxed cells were incubated
with mouse primary antibody avb5-heterodimer-speciﬁc antibody
P1F6 (1:100 dilution; Millipore, USA) or avb6-heterodimer-speciﬁc
antibody E7P6 (1:100 dilution; Millipore, USA) at 4 C overnight,
washed with PBS and followed by incubation with goat anti-mouse
secondary antibody conjugated to cyanine 3 (Cy3; 1:100 dilution;
Beyotime, Shanghai, China) at 37 C for 1 h. Nuclei were stained
with DAPI (Hyclone, USA). The integrin avb5 or avb6 expression
was observed under Leica Confocal Microscope (Leica Microsys-
tems, Wetzlar, Germany). The ﬂuorescence intensity of individual
cells was measured and analyzed with the NIH ImageJ image soft-
ware (http://rsb.info.nih.gov/ij/).
2.6. Flow cytometry
Subconﬂuent HaCaT keratinocytes were washed with PBS, tryp-
sinized and resuspended in FACS buffer (PBS containing 1 mM
MgCl2 and 0.1% BSA). Cells were incubated with antibody P1F6 or
E7P6 at 4 C for 40 min and washed twice with PBS. Alexa Fluor
488 Goat anti-mouse secondary antibody (1:100 dilution; Invitro-
gen, USA) was applied to the cells at 4 C for 30 min. Cells were
washed twice with PBS and resuspended in 0.5 mL PBS with 10%
fetal bovine serum. Labelled cells were subsequently analysed on
a FACScans ﬂow cytometer using Cellquest software (Beckton
Dickinson).
2.7. Cell scratch wounding assay and time-lapse videomicroscopy
Scratch wounding assay was performed as we described previ-
ously [8]. HaCaT Cells infected with recombinant adenoviruses
were grown to conﬂuence in the 24-well plates in serum condi-
tioned RPMI 1640. Scratch wounds were created in conﬂuent mon-
olayers using a sterile 20 lL pipette tip and different ﬁelds were
ﬁlmed for 20 h using a Zeiss videomicroscope then analysed using
the NIH ImageJ image software (http://rsb.info.nih.gov/ij/). For
inhibition experiments, avb6 function blocking antibody 10D5
(10 lg/mL) or avb5 function blocking antibody P1F6 (10 lg/mL)
was added into RPMI 1640 medium at 37 C for 30 min before
scratching.
2.8. In vitro cell migration assays
Cell-migration assays were performed using polycarbonate
ﬁlters (8 mm pore size, Transwell; BectonDickinson, USA). For inhi-
bition experiments, function blocking antibody 10D5 or P1F6
(10 lg/mL) was added into upper and lower chambers. The lower
chamber was ﬁlled with 600 lL of RPMI 1640 medium supple-
mented with 10% FBS, and the cells were plated at a density of
3  105 in 100 mL of migration buffer in the upper chamber of trip-
licate wells followed the incubation at 37 C for 20 h. Then the
transwell inserts were ﬁxed with 10% formalin, stained with 0.5%
crystal violet in 10% ethanol for 10 min and washed with PBS for
three times. Cells in the upper compartment were removed using
a cotton wool swab, and the ﬁlter was mounted onto glass slides.
Cells from ﬁve random ﬁelds were counted under 100magniﬁca-
tion. Mean cell numbers for each sample were from triplicate
inserts.
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Gelatinase activity in the supernatants of HaCaT cells was deter-
mined using SDS–PAGE as previously described [8]. Brieﬂy, the
conditioned media were concentrated and harvested. The samples
were electrophoresed on 10% polyacrylamide gels copolymerized
with 1 mg/mL gelatin. After electrophoresis, the gel was washed
twice in 2% Triton-X-100 (Sigma, USA) for 10 min and then incu-
bated in incubation buffer at 37 C overnight. After incubation,
the gel was stained with 0.5% Coomassie Brilliant Blue (Beyotime,
Shanghai, China) and destained with gel-clear destaining solution.
Gelatinolytic activities were detected as transparent bands against
a background of Coomassie Brilliant Blue-stained gelatin. The sig-
nal intensities of the products were measured using SCIONIMAGE
analysis software.
2.10. Statistical analysis
Statistical analysis was carried out using either Student’s t-test
or one-way ANOVA for the comparison of more than two groups.
The data are presented as means ± S.D. of at least three indepen-
dent experiments. A value of P < 0.05 was considered statistically
signiﬁcant.
3. Results
3.1. CD9 regulated integrin expressions in keratinocytes
To analyze which kind of integrin subunit was associated with
CD9 in keratinocytes, HaCaT cells were infected with recombinant
adenovirus vectors to silence CD9 (siCD9) or overexpress CD9
(Ad-CD9). After 48 h, more than 90% of the keratinocytes were
conﬁrmed to be infected by observing GFP expression using a ﬂuo-
rescent microscope. The effective endogenous CD9 silencing or
CD9-GFP fusion protein overexpression was conﬁrmed using Wes-
tern blot (Fig. S1). We then analyzed the expressions of integrin
subunits b5, b6, b1, av, and a3 in CD9-regulated HaCaT cells using
Western blot (Fig. 1). We found that the protein level of integrinFig. 1. CD9 regulated integrin expressions in keratinocytes. HaCaT keratinocytes were i
overexpress CD9 (Ad-CD9) and negative vectors (siCtr and Vector group). (a) Western blo
graph represents the mean ± S.D. (n = 3) of the relative integrated signals. ⁄P < 0.05 vs. ssubunit b5 was reduced in CD9-silenced keratinocytes, while
subunit b6 was induced. Moreover, in CD9-overexpressed
keratinocytes, the protein level of b5 increased while the b6
decreased. The other integrin subunits b1, av, and a3 showed no
difference between negative vector-infected cells (siCtr or Vector)
and CD9-regulated cells (siCD9 or Ad-CD9). These results indicated
that integrin subunits b5 and b6 were regulated by CD9 in
keratinocytes.
3.2. Downregulating CD9 induced a switch from avb5 to avb6
The integrin subunits b5 and b6 only combine with av integrin,
and the combined integrins function in the plasma membrane to
transfer outside-in or inside-out signaling [30]. Hence, we then
detected the change of integrins avb5 to avb6 in CD9-regulated
keratinocytes. The plasma membrane of HaCaT cells was isolated,
and the complex was analyzed by immunoprecipitation with an
antibody against integrin subunit av, followed by Western blot
with the antibodies against integrin subunits b5 and b6. The results
showed that CD9 downregulation induced the formation of integrin
avb6 at the plasmamembrane, and CD9 overexpression reduced its
formation. Additionally, the formation of integrin avb5 at the
plasma membrane increased in CD9-overexpressed HaCaT cells,
while decreased in CD9-silenced cells (Fig. 2a and b). Furthermore,
ﬂuorescence immunostaining and ﬂow cytometry assay both
conﬁrmed that integrins avb5 and avb6 mainly distributed at the
plasma membrane of keratinocytes. Integrin avb5 expression
was downregulated in CD9-silenced cells and upregulated in CD9-
overexpressed cells, while the avb6 expression increased in the
CD9-silenced cells and decreased in CD9-overexpressed cells
(Fig. 2c–e). Taken together, these results demonstrate that the
switch from avb5 to avb6 is triggered by CD9 downregulation
and blocked by CD9 overexpression.
3.3. avb6 was involved in CD9-regulated keratinocyte migration
Our previous results revealed that CD9 is critical for wound
healing, and CD9 downregulation contributes to keratinocytenfected with recombinant adenovirus vectors for silence CD9 expression (siCD9) or
t analysis for the effect of CD9 on the integrin subunits b5, b6, b1, av, and a3. (b) The
iCtr group; #P < 0.05 vs. Vector group.
Fig. 2. Downregulating CD9 induced a switch from avb5 to avb6. HaCaT keratinocytes were infected with recombinant adenovirus vectors to silence CD9 expression (siCD9)
or overexpress CD9 (Ad-CD9) and negative vectors (siCtr and Vector group). (a) The cells were harvested and the plasma membrane lysates were extracted. The complex
formation was analyzed by immunoprecipitation (IP) with integrin subunit av antibody followed by immunoblotting with the integrin subunits b5, b6, and av antibody. (b)
The graph represents the mean ± S.D. (n = 3) of the relative integrated signals. ⁄P < 0.05 vs. siCtr group; #P < 0.05 vs. Vector group. (c) Immunoﬂuorescence analysis of integrins
avb5 and avb6 in CD9-regulated HaCaT cells (red labelling); nuclei were stained with DAPI (blue). Scale bar = 50 lm. (d) Quantitative analyses were performed with Image J
software. The ﬂuorescence intensity of avb5 and avb6 staining was normalized using the nuclei ﬂuorescence values. ⁄P < 0.05 vs. siCD9 group. (e) FACS analysis of integrins
avb5 and avb6 in CD9-regulated HaCaT cells were shown. IgG was used as a negative control (control).
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avb6 promotes keratinocyte migration [28,29]. To determine
whether the integrin switch from avb5 to avb6 is involved inCD9-regulated cell migration, we examined the effects of antibody
10D5 functionally blocking avb6 and antibody P1F6 blocking avb5
on the migration of CD9-regulated HaCaT keratinocytes using cell
Fig. 3. avb6 was involved in CD9-regulated keratinocyte migration. (a) HaCaT cells infected with recombinant adenovirus vectors to silence CD9 expression (siCD9) and
negative vectors (siCtr) were scratch-wounded with a micropipette tip after incubation with 10D5 (10 lg/mL) and ﬁlmed for 20 h using time-lapse videomicroscopy. Wound
closure is illustrated by showing the wound size immediately and 20 h after scratching. Scale bar = 100 lm. (b) The panel represents the quantiﬁcation of the 10D5 effect on
the wound closure calculated by the diminution of the wound bed surface upon time using Image J software. (c) Recombinant adenovirus-infected HaCaT cells were
pretreated with 10D5 (10 lg/mL) at 37 C for 30 min and then seeded in the upper chambers of transwell inserts. After 20 h, cells on the lower side of the ﬁlter were stained
with 0.5% crystal violet and scored in ﬁve independent ﬁelds (n = 3). (d–f) HaCaT cells were infected with recombinant adenovirus vectors to overexpress CD9 (Ad-CD9) and
negative vectors (Vector). P1F6 (10 lg/ml) was used to observe the effect of integrin avb5 on wound closure and cell migration. ⁄P < 0.05 vs. siCD9 group; #P < 0.05 vs. siCtr
group.
4048 X. Jiang et al. / FEBS Letters 588 (2014) 4044–4052
Fig. 4. Inhibition of avb6 blocked CD9 downregulation-induced MMP-9 expression. (a) Gelatin zymograms and quantitative analysis were shown for MMP-9 and MMP-2
activity in the culture supernatants (n = 3). Negative vector-infected (siCtr) and CD9-silencing HaCaT cells (siCD9) were treated with integrin avb6 functional blocking
antibody 10D5 (10 lg/mL). (b) Representative Western blot results and data summary of MMP-9 in CD9-silenced HaCaT cells with or without 10D5 (n = 3). (c) Gelatin
zymograms and quantitative analysis were shown for activity of MMP-9 and MMP-2 in the culture supernatants (n = 3). Negative vector-infected (Vector) and CD9-
overexpressed HaCaT cells (Ad-CD9) were treated with integrin avb5 functional blocking antibody P1F6 (10 lg/mL). (d) Representative Western blot results and data
summary of MMP-9 in CD9-overexpressed HaCaT cells with or without P1F6 (n = 3). ⁄P < 0.05 vs. siCD9 group; #P < 0.05 vs. siCtr group.
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20 h, CD9-silenced HaCaT cells migrated into over 90% of the
scratched area (siCD9 group), while these cells occupied only 52%
after inhibiting integrin avb6. In addition, wound closure was
reduced to less than 10% in the scramble-infected HaCaT keratino-
cytes (siCtr group) after the integrin avb6 functional inhibition
(Movie 1, Fig. 3a and b). No difference in cell proliferation wasdetected in these groups (data not shown). Thus, cell proliferation
could be excluded as a possible explanation for migratory capacity
alternation of integrin avb6 in CD9-regulated keratinocytes. The
regulatory role of integrin avb6 in CD9-regulated cell migration
was further conﬁrmed by the transwell migration assay. The num-
ber of cells migrating through the porous of transwell chamber
membranes decreased by 56% in CD9-silenced HaCaT cells after
4050 X. Jiang et al. / FEBS Letters 588 (2014) 4044–4052the integrin avb6 was functionally blocked compared to the siCD9
group (Fig. 3c). Furthermore, our results revealed that the integrin
avb5 functional blocking antibody P1F6 had no signiﬁcant effect
on the CD9- overexpressed HaCaT cell migration (Movie 2,
Fig. 3d–f). Hence, our ﬁndings suggest that the switch from avb5
to avb6 participates in CD9-regulated keratinocyte migration.
3.4. Inhibition of avb6 blocked CD9 downregulation-induced MMP-9
activation
We previously found that CD9 downregulation induced MMP-9
activation in keratinocytes, which plays an important role in CD9-
regulated cell migration [8] and avb6 also upregulates MMP-9
[26]. So, we hypothesized that the switch from avb5 to avb6 stim-
ulates MMP-9 activation and expression in CD9-silenced HaCaT
keratinocytes. The involvement of integrins avb6 and avb5 in
CD9 silencing-induced MMP-9 activation in HaCaT cells was inves-
tigated using functional blocking antibodies 10D5 and P1F6. HaCaT
cells infected with CD9-shRNA vector (siCD9) and negative vector
(siCtr) were both treated with 10D5 (10 lg/mL). Our data demon-
strated that 10D5 signiﬁcantly abolished MMP-9 activity in the
culture supernatants of CD9-silenced HaCaT cells, whereas no
change was detected in MMP-2 activity (Fig. 4a). The MMP-9
protein level in CD9-silenced HaCaT cells was also reduced by inte-
grin avb6 functional blocking (Fig. 4b). Moreover, the integrin
avb5 functional blocking antibody had no effect on MMP-9 activa-
tion and expression in CD9-overexpressed HaCaT cells (Fig. 4c and
d). The combined results indicate that the switch from avb5 to
avb6 plays a crucial role in the CD9-regulated MMP-9 activation
process.
4. Discussion
Although increasing studies have shown CD9 is implicated in
cell migration, and our previous results revealed it is critical for
keratinocyte migration and MMP-9 activation, little is known
about its underlying mechanisms. To our knowledge, this study
is the ﬁrst to directly examine the role of integrin switching in
the CD9-regulated cell migration and MMP-9 activation in
keratinocytes. We demonstrated that integrin avb5 switched to
avb6 in HaCaT keratinocytes when CD9 was downregulated. Fur-
thermore, we found that the integrin switch from avb5 to avb6
was involved in the CD9-regulated cell migration and MMP-9
expression.
Tetraspanin CD9 is expressed in keratinocytes and was found in
normal epidermis more than ten years ago [31]. CD9 is highly
expressed by keratinocytes, clearly delineating ﬁlopodia at lateral
and apical surfaces, and CD9 accumulates with integrins at inter-
cellular junctions [32]. The association between tetraspanins and
integrins has been described in different cell types, and CD9 partic-
ipates with integrins in keratinocyte physiology control [33,34].
Here, we found that CD9 silencing stimulated the expression of
integrin avb6 in HaCaT keratinotytes, accompanied with downreg-
ulated avb5. In fact, expression of the integrin avb6 appears to be
restricted to a subset of epithelial cells and is not detectable in nor-
mal keratinocytes [35], while avb5 is expressed in the epidermis
[20]. During cutaneous wound healing, integrin avb6 is upregu-
lated in migrating keratinocytes associated with avb5 downregula-
tion [21]. We previously found that CD9 is downregulated in
migrating epidermis and re-elevated to the basal level when re-
epithelialization is complete [4]. The change of integrin avb6 and
avb5 expressions spatiotemporally correlates well with the CD9
downregulation in migrating keratinocytes at the wound edge.
Indeed, although the de novo expression of avb6 by wound kerat-
inocytes is well documented, the molecular mechanisms leading toits expression are still unclear. Our present results revealed that
the switch from integrin avb5 to avb6 was regulated by CD9.
Indeed, one of the most peculiar features of tetraspanins is their
ability to associate with integrins, other tetraspanins and signaling
receptors, forming tetraspanin- enriched microdomains on the cell
surface [36,6]. The association of CD9 with certain integrins has
been observed in different cell types [37], and CD9-integrin com-
plexes are highly speciﬁc for a given cell type. CD9 reportedly
interacts with integrin a5b1 in myocytes [38], a6b4 in keratino-
cytes [39], avb3 in endothelial cell migration [40], and aIIb3 in
platelets [41]. CD9 is also implicated in the regulation of integrins
a3, a5, b1, and b5 [24,42]. In the present study, we found that CD9
was also involved in the regulation of integrin subunits b5 and b6
in keratinocytes, and CD9 downregulation promoted the switch
from avb5 to avb6. The collective data indicates that CD9 may
partly be responsible for integrin regulation.
De novo avb6 expression modulates several cellular processes
in carcinoma cells, including cell adhesion, migration, and spread-
ing on ﬁbronectin [43,44]. Several studies have found that avb6
expression promotes keratinocyte migration. By using mouse
b6/, Huang et al. revealed that avb6 is critical to keratinocyte
migration over ﬁbronectin and vitronectin [29]. In human primary
oral keratinocytes, avb6 also promotes cell migration on ﬁbronec-
tin [26]. In this report, we demonstrated CD9 silencing-induced
keratinocyte migration could be blocked with speciﬁc anti-avb6
antibody but not by antibody against avb5, which indicated that
integrin avb6 rather than avb5 is involved in CD9 silencing-
induced keratinocyte migration. Meanwhile, this phenomenon is
similar to those seen in squamous cell carcinoma, where de novo
avb6 expression is often correlated with loss of avb5 expression,
which regulates carcinoma cells behavior [45,46].
Integrins affect MMP-9 expression in several cell systems
[27,47]. MMP-9 upregulation plays an important role in wound
re-epithelialization and keratinocyte migration [48–50]. Our
previous study also found that CD9 participates in keratinocyte
migration via regulating MMP-9 during wound healing [4,8]. Fur-
thermore, avb6 plays a functional role in keratinocyte migration
by upregulating MMP-9 [26,51]. To determine whether the switch
from integrin avb5 to avb6 is involved in CD9-regulated MMP-9
activation in keratinocytes, we used functional blocking antibodies
to inhibit the functions of integrins avb5 and avb6. Our results
showed that anti-avb6 antibody blocked the CD9 silencing-
induced MMP-9 activation and expression, while anti-avb5
antibody had no effect on the CD9-mediated MMP-9 change. The
ability of integrins to regulate the signaling molecule targeting is
important to determine cell polarity and direct cell migration
[52]. The microtubule-based cytoskeleton is also regulated by the
integrin signal. Many studies highlight the interface between inte-
grins and cytoskeletal components in regulating polarity and
motility [13,14]. MMP-9 is also required for tubular network for-
mation [53] and actin cytoskeletal organization [54], which are
essential to cell migration. MMP-9 also localizes to the terminal
aspects of avb6-positive keratinocyte ﬁlopodia, which indicates
avb6 and MMP-9 may be involved in cytoskeletal organization
and then regulates cell migration [26]. The integrin switch from
avb5 to avb6 triggered by CD9 downregulation may modulate out-
side-in signaling in keratinocytes which regulates MMP-9 activa-
tion and cell migration.
In summary, our ﬁndings demonstrated that CD9 downregula-
tion triggered the switch from avb5 to avb6 integrin in keratino-
cytes, which was critical for cell migration and MMP-9 activation
and expression. Moreover, as previously mentioned, CD9 is down-
regulated in migrating keratinocytes, which is involved in the
regulation of cell migration and MMP-9 activation during wound
healing [4,8]. Therefore, we believe that our ﬁndings on the
X. Jiang et al. / FEBS Letters 588 (2014) 4044–4052 4051CD9-mediated switch from avb5 to avb6 integrin can give new
insights into the role of CD9 in wound repair.
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